Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 716
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT06667687 Study to Evaluate Adverse Events, Change in Disease Activity, and How I… |
ABBV-291 | Cancer | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | AbbVie | United States, Australia, Israel, Japan, United Kingd… | 2025-01-16 → 2027-04 | Ouvrir |
| NCT06157801 Evaluation of Hereditary Cancer Educational Videos |
Evaluation of Hereditary Cancer E… | Cancer | À vérifier | ACTIVE_NOT_RECRUITING | En attente / non publié | M.D. Anderson Cancer Center | United States · MD Anderson Cancer Center, Houston, U… | 2024-04-05 → 2027-10-31 | Ouvrir |
| NCT07313332 ReHIIT_CON — Exploring Resistance Exercise Training Plus High-Intensity… |
ReHIIT_CON — Exploring Resistance… | Cancer | Non applicable | RECRUITING | En attente / non publié | University of Nottingham | United Kingdom · Medical School, University of Nottin… | 2026-01-01 → 2027-12-01 | Ouvrir |
| NCT07262567 Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRA… |
GFH375 | Cancer | Phase 3 | RECRUITING | En attente / non publié | Genfleet Therapeutics (Shanghai) … | China · Peking University Cancer Hospital & Institute… | 2025-12-04 → 2028-06 | Ouvrir |
| NCT07737951 Tai Chi for Reducing Aromatase Inhibitor-Induced Arthralgia |
Tai Chi for Reducing Aromatase In… | Cancer | Non applicable | RECRUITING | En attente / non publié | Thomas Jefferson University | United States · Sidney Kimmel Cancer Center at Thomas… | 2026-07-27 → 2029-06 | Ouvrir |
| NCT07543536 MEGA-TACT-BC3 — Megestrol Acetate for Fatigue Management in T-DXd Treat… |
Megestrol Acetate + Trastuzumab D… | Cancer | Phase 3 | RECRUITING | En attente / non publié | Sun Yat-sen University | China · Sun Yat-sen University Cancer Center, Guangzh… | 2026-06-08 → 2031-04-01 | Ouvrir |
| NCT05259839 A Study to Assess Adverse Events and Change in Disease Activity of Intr… |
Etentamig | Cancer | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | AbbVie | United States, Australia, Germany, Italy, Japan, Pola… | 2022-10-20 → 2033-09 | Ouvrir |
| NCT05057676 AIM — Autoimmune Intervention Mastery Course Study |
AIM — Autoimmune Intervention Mas… | Myopathies | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | Terry L. Wahls | United States · Univeristy of Iowa, Iowa City, United… | 2021-12-01 → 2027-12-01 | Ouvrir |
| NCT07766122 ECETEP — Analysis of the Performance of PSMA Emission Tomography in Pat… |
Nuclear imaging (PSMA PET) with i… | Cancer | Phase 4 | NOT_YET_RECRUITING | En attente / non publié | University Hospital, Toulouse | France · University Hospital of Toulouse, Toulouse, F… | 2026-10 → 2028-10 | Ouvrir |
| NCT06312137 TroFuse-019 — A Study to Assess Efficacy and Safety of Pembrolizumab Wi… |
Sacituzumab Tirumotecan | Cancer | Phase 3 | RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Argentina, Australia, Austria, Belgium… | 2024-04-03 → 2034-10-23 | Ouvrir |
| NCT04401020 First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL |
SAR442257 | Cancer | Phase 1 | TERMINATED | En attente / non publié | Sanofi | United States, Czechia, Norway, South Korea, Spain · … | 2020-07-24 → 2026-05-11 | Ouvrir |
| NCT05675410 A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Us… |
Biospecimen Collection | Cancer | Phase 3 | RECRUITING | En attente / non publié | Roswell Park Cancer Institute | United States, Canada, Puerto Rico · Abbott-Northwest… | 2023-05-11 → 2031-04-28 | Ouvrir |
| NCT06253520 Autologous T-cells Genetically Engineered to Express Receptors Reactive… |
aldesleukin | Cancer | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2024-05-16 → 2029-02-20 | Ouvrir |
| NCT04367675 INO 5401 Vaccination in BRCA1/2 Mutation Carriers |
INO-5401 | Cancer | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | Abramson Cancer Center at Penn Me… | United States · University of Pennsylvania, Philadelp… | 2021-04-20 → 2027-03 | Ouvrir |
| NCT00974948 Trial of Endoscopic Ultrasound (EUS) - Guided Celiac Plexus Neurolysis |
EUS-guided celiac plexus neurolys… | Cancer | Phase 3 | COMPLETED | En attente / non publié | Centre hospitalier de l'Universit… | Canada · CHUM, Montreal, Canada | 2006-04 → 2008-12 | Ouvrir |
| NCT04235777 Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Ster… |
Stereotactic Body Radiation Thera… | Cancer | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | University of Wisconsin, Madison | United States · National Institutes of Health Clinica… | 2020-07-13 → 2028-12-01 | Ouvrir |
| NCT04115267 Attribution of Toxicities Due to Radiotherapy and Immuno-Biological The… |
Radiotherapy | Cancer | À vérifier | RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | Canada · Centre Hospitalier de l'Universite de Montre… | 2019-09-13 → 2030-09-30 | Ouvrir |
| NCT06568939 A Study to Assess Adverse Events and How Intravenously (IV) Infused Tel… |
Telisotuzumab Vedotin | Cancer | Phase 2 | RECRUITING | En attente / non publié | AbbVie | United States, Brazil, China, Israel, Japan, Serbia, … | 2025-01-20 → 2028-02 | Ouvrir |
| NCT05256225 Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemot… |
Biospecimen Collection | Cancer | Phase 3 | RECRUITING | En attente / non publié | Roswell Park Cancer Institute | United States, Puerto Rico, South Korea · Abbott-Nort… | 2022-11-16 → 2027-10-31 | Ouvrir |
| NCT07419295 TroFuse-031 — A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-… |
Sacituzumab Tirumotecan | Cancer | Phase 3 | RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Argentina, Australia, Belgium, Brazil,… | 2026-04-23 → 2030-04-23 | Ouvrir |
| NCT04812366 GUNS — Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High R… |
Apalutamide 60mg Tab | Cancer | Phase 2 | RECRUITING | En attente / non publié | University of British Columbia | United States, Canada · Dana-Farber Cancer Institute … | 2021-09-21 → 2027-06-01 | Ouvrir |
| NCT07549412 A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared… |
Precemtabart tocentecan | Cancer | Phase 3 | RECRUITING | En attente / non publié | EMD Serono Research & Development… | United States, Australia, Canada, China, Japan, South… | 2026-05-06 → 2029-10-16 | Ouvrir |
| NCT05025059 Exercise During Chemotherapy in Older Women With Stage I-III Breast Can… |
Discussion | Cancer | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | M.D. Anderson Cancer Center | United States · M D Anderson Cancer Center, Houston, … | 2020-12-03 → 2026-12-31 | Ouvrir |
| NCT03652545 REMIND — Multi-antigen T Cell Infusion Against Neuro-oncologic Disease |
TAA-T | Cancer | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | Catherine Bollard | United States · Brain Tumor Institute, Children's Nat… | 2018-12-12 → 2028-12 | Ouvrir |
| NCT03283605 Immunotherapy and SBRT for Metastatic Head and Neck Carcinomas |
SBRT | Cancer | Phase 1/2 | COMPLETED | En attente / non publié | Centre hospitalier de l'Universit… | Canada · Centre Hospitalier de l'Universite de Montre… | 2018-07-17 → 2024-12-31 | Ouvrir |